Dashboard
Manage Tickers

TFFPTFF Pharmaceuticals, Inc.

Nasdaq tffpharma.com


$ 2.20 $ 0.19 (9.45 %)    

Thursday, 16-May-2024 15:59:30 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 451.64 $ -1.83 (-0.4 %)
DIA $ 399.14 $ -0.14 (-0.04 %)
SPY $ 528.49 $ -1.29 (-0.24 %)
TLT $ 92.06 $ -0.04 (-0.04 %)
GLD $ 220.06 $ -0.83 (-0.38 %)
$ 2.16
$ 2.07
$ 0.00 x 0
$ 0.00 x 0
$ 2.07 - $ 2.38
$ 1.54 - $ 17.02
50,164
na
6.23M
$ 2.43
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 03-28-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-31-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-11-2022 03-31-2022 10-Q
10 03-24-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-13-2021 03-31-2021 10-Q
14 03-10-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-13-2020 06-30-2020 10-Q
17 05-14-2020 03-31-2020 10-Q
18 03-27-2020 12-31-2019 10-K
19 12-09-2019 09-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
05/16/2024 20:31:13

tff-pharmaceuticals-provided-an-update-from-its-ongoing-phase-2-trial-of-tacrolimus-inhalation-powder-for-the-prevention-of-lung-transplant-rejection
TFF Pharmaceuticals Provided An Update Fro...
05/15/2024 11:14:25

Patient Enrollment Has Accelerated with Now 10 Patients Enrolled in Phase 2 Trial. 6 out of 6 Patients Who Completed the 12-...

tff-pharmaceuticals-expects-to-receive-fda-feedback-in-q2-regarding-tff-tac-clinical-development-plan-and-next-steps
TFF Pharmaceuticals Expects To Receive FDA...
05/14/2024 20:43:29

tff-pharmaceuticals-q1-2024-gaap-eps-240-misses-226-estimate-sales-20327k-beat-7500k-estimate
TFF Pharmaceuticals Q1 2024 GAAP EPS $(2.4...
05/14/2024 20:42:36

TFF Pharmaceuticals (NASDAQ:TFFP) reported quarterly losses of $(2.40) per share which missed the analyst consensus estimate of...

reported-earlier-tff-pharmaceuticals-prices-48m-public-offering-of-1665219-shares-and-warrants-at-2875share-accompanying-warrant
Reported Earlier, TFF Pharmaceuticals Pric...
04/30/2024 08:35:41

TFF Pharmaceuticals announced the pricing of a public offering of an aggregate of 1,665,219 shares of its common stock (or comm...

tff-pharmaceuticals-makes-available-phase-2-data-from-tacrolimus-inhalation-powder-for-the-prevention-of-lung-transplant-rejection-presented-at-the-recent-ishlt-annual-meeting
TFF Pharmaceuticals Makes Available Phase ...
04/29/2024 14:01:46

Data Now Available on Company Website Following 8-K Filing Data Demonstrate that Treatment with TFF TAC Prevents Lung Transplan...

tff-pharmaceuticals-announces-additional-data-from-the-tacrolimus-inhalation-powder-tff-tac-phase-2-trial-following-oral-presentation-at-the-ishlt-44th-annual-late-breaking-clinical-science-abstract-sessions
TFF Pharmaceuticals Announces Additional D...
04/15/2024 11:11:19

TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) ("the Company"), a clinical-stage biopharmaceutical company focused on developi...

tff-pharmaceuticals-q4-eps-201-beats-212-estimate-sales-11433k-beat-10000k-estimate
TFF Pharmaceuticals Q4 EPS $(2.01) Beats $...
03/28/2024 20:20:29

TFF Pharmaceuticals (NASDAQ:TFFP) reported quarterly losses of $(2.01) per share which beat the analyst consensus estimate of $...

roth-mkm-maintains-buy-on-tff-pharmaceuticals-lowers-price-target-to-44
Roth MKM Maintains Buy on TFF Pharmaceutic...
03/28/2024 17:01:12

Roth MKM analyst Jonathan Aschoff maintains TFF Pharmaceuticals (NASDAQ:TFFP) with a Buy and lowers the price target from $5...

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
03/27/2024 20:31:13

tff-pharmaceuticals-announces-updated-data-from-tacrolimus-inhalation-powder-voriconazole-inhalation-powder-clinical-programs-says-eight-of-eight-patients-successfully-transitioned-from-oral-tacrolimus-to-tff-tac-with-no-sign-of-acute-rejection-at-reduced-systemic-exposures
TFF Pharmaceuticals Announces Updated Data...
03/27/2024 20:05:19

tff-pharmaceuticals-announces-oral-presentation-of-interim-data-from-the-phase-2-study-of-tacrolimus-inhalation-powder-for-the-prevention-of-lung-transplant-rejection-at-the-44th-annual-ishlt-2024-meeting
TFF Pharmaceuticals Announces Oral Present...
03/25/2024 13:16:22

TFF Pharmaceuticals, Inc. (NASDAQ:TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing i...

tff-pharmaceuticals-announces-12m-registered-direct-offering-of-147500-shares-at-800share
TFF Pharmaceuticals Announces $1.2M Regist...
03/20/2024 16:02:39

tff-pharmaceuticals-announces-clinical-programs-update-and-strategic-prioritization-company-to-prioritize-tff-tac-program-based-on-phase-2-data
TFF Pharmaceuticals Announces Clinical Pro...
03/20/2024 13:10:28

Company to Prioritize Clinical Development of Tacrolimus Inhalation Powder (TFF TAC) based on Positive Phase 2 Data, the Potent...

tff-pharmaceuticals-to-present-data-from-phase-2-trial-of-voriconazole-inhalation-powder-for-treatment-of-invasive-pulmonary-aspergillosis-at-11th-advances-against-aspergillosis--mucormycosis-conference
TFF Pharmaceuticals To Present Data From P...
01/24/2024 13:17:10

tff-pharmaceuticals-announces-acceptance-of-late-breaking-abstract-for-presentation-at-the-44th-annual-international-society-for-heart-and-lung-transplantation-2024-meeting
TFF Pharmaceuticals Announces Acceptance O...
01/09/2024 13:13:17

TFF Pharmaceuticals, Inc. (NASDAQ:TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing i...

bluebird-bio-vertex-energy-and-other-big-stocks-moving-lower-on-tuesday
Bluebird Bio, Vertex Energy And Other Big ...
12/19/2023 15:19:40

U.S. stocks traded higher, with the Dow Jones index gaining around 150 points on Tuesday. Shares of bluebird bio, Inc. (NASDA...

tff-pharmaceuticals-announced-initial-data-from-its-ongoing-phase-2-trials-of-tff-vori-and-tff-tac-along-with-clinical-data-from-the-ongoing-tff-vori-expanded-access-program
TFF Pharmaceuticals Announced Initial Data...
12/19/2023 11:05:25

tff-pharmaceuticals-to-hold-conference-call-and-webcast-to-review-initial-data-from-ongoing-phase-2-trials-of-tff-vori-and-tff-tac-on-dec-19-at-830-am-et
TFF Pharmaceuticals To Hold Conference Cal...
12/18/2023 21:04:15

tff-pharmaceuticals-announces-reverse-stock-split-at-a-ratio-of-1-post-split-share-for-every-25-pre-split-shares
TFF Pharmaceuticals Announces Reverse Stoc...
12/15/2023 12:04:20

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION